Martha E. Fay
Harvard University
22 Papers
446 Citations
Martha E. Fay is an academic researcher from Harvard University. The author has contributed to research in topics: Randomized controlled trial & Stroke. The author has an hindex of 18, co-authored 22 publications.
Chat about Author
Papers
An Association between Air Pollution and Mortality in Six U.S. Cities
Douglas W. Dockery,C A Pope rd,X Xu,John D. Spengler,James H. Ware,Martha E. Fay,Benjamin G. Ferris,Frank E. Speizer +7 more
TL;DR: It is suggested that fine-particulate air pollution, or a more complex pollution mixture associated with fine particulate matter, contributes to excess mortality in certain U.S. cities.
8K
Pulmonary function between 6 and 18 years of age.
TL;DR: Race‐, sex‐, and age‐specific regression equations based on height are provided, which permit the evaluation of growth during adolescence with improved accuracy and, more importantly, in comparison with previous observations for the same child.
653
Neighborhood Contextual Influences on Depressive Symptoms in the Elderly
Laura D. Kubzansky,Sankaran Subramanian,Ichiro Kawachi,Martha E. Fay,Mah-J Soobader,Lisa F. Berkman +5 more
TL;DR: The authors found no evidence that access to services hypothesized to promote social engagement, to provide health services, or to affect the reputation of a neighborhood explained (i.e., mediated) neighborhood variations in depressive symptoms.
Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities.
Douglas W. Dockery,James H. Ware,Benjamin G. Ferris,David S. Glicksberg,Martha E. Fay,Avron Spiro,Frank E. Speizer +6 more
TL;DR: Subjects in the lowest quartile of FEV1/HT2 for their age and sex at the first examination had a lower probability of providing a lung function measurement 3 yr later, showing a nonlinear relationship consistent with an increase in the rate of pulmonary function loss with age.
235
Effect of Chelation Therapy on the Neuropsychological and Behavioral Development of Lead-Exposed Children After School Entry
Kim N. Dietrich,James H. Ware,M.P. Salganik,Jerilynn Radcliffe,Walter J. Rogan,George G. Rhoads,Martha E. Fay,Cecilia T Davoli,Martha B Denckla,Robert L. Bornschein,Donald F. Schwarz,Douglas W. Dockery,Susan Adubato,Robert L. Jones +13 more
TL;DR: These new follow-up data confirm the previous finding that the TLC regimen of chelation therapy is not associated with neurodevelopmental benefits in children with blood lead levels between 20 and 44 microg/dL (0.96-2.12 micromol/L).
196